Literature DB >> 18486253

Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma.

Pietro Mancosu1, Valentino Bettinardi, Paolo Passoni, Simone Gusmini, Stefano Cappio, Maria C Gilardi, Giovanni M Cattaneo, Michele Reni, Alessandro Del Maschio, Nadia Di Muzio, Ferruccio Fazio.   

Abstract

A procedure to improve target volume definition in pancreatic ductal adenocarcinoma by contrast enhanced 4D-CT imaging has been implemented for radiotherapy planning. The procedure allows good quality images to be obtained over the whole patient's breathing cycle in terms of anatomical details, pancreatic enhancement and vessel definition.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18486253     DOI： 10.1016/j.radonc.2008.04.007

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


  11 in total

Review 1.  Stereotactic body radiotherapy for the pancreas: a critical review for the medical oncologist.

Authors:  Samuel K Kim; Cheng-Chia Wu; David P Horowitz
Journal:  J Gastrointest Oncol       Date:  2016-06

2.  Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer.

Authors:  Jordan Kharofa; Susan Tsai; Tracy Kelly; Clint Wood; Ben George; Paul Ritch; Lauren Wiebe; Kathleen Christians; Douglas B Evans; Beth Erickson
Journal:  Radiother Oncol       Date:  2014-10-15       Impact factor: 6.280

3.  Individually optimized contrast-enhanced 4D-CT for radiotherapy simulation in pancreatic ductal adenocarcinoma.

Authors:  Wookjin Choi; Ming Xue; Barton F Lane; Min Kyu Kang; Kruti Patel; William F Regine; Paul Klahr; Jiahui Wang; Shifeng Chen; Warren D'Souza; Wei Lu
Journal:  Med Phys       Date:  2016-10       Impact factor: 4.071

Review 4.  New era of radiotherapy: an update in radiation-induced lung disease.

Authors:  M F K Benveniste; J Welsh; M C B Godoy; S L Betancourt; O R Mawlawi; R F Munden
Journal:  Clin Radiol       Date:  2013-03-06       Impact factor: 2.350

5.  Feasibility of 4D CT simulation with synchronized intravenous contrast injection in hepatocellular carcinoma.

Authors:  Anil Gupta; Rishabh Kumar; Hanuman Prasad Yadav; Manik Sharma; Rose Kamal; Deepak Thaper; Prabir Banik; Shipra Gupta; Kartik Saroha; Sandeep Singh; Shiv Kumar Sarin
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-13

6.  Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The dummy run.

Authors:  Eva Versteijne; Eelco Lens; Astrid van der Horst; Arjan Bel; Jorrit Visser; Cornelis J A Punt; Mustafa Suker; Casper H J van Eijck; Geertjan van Tienhoven
Journal:  Strahlenther Onkol       Date:  2017-06-12       Impact factor: 3.621

7.  Intravenous contrast-enhanced cone beam computed tomography (IVCBCT) of intrahepatic tumors and vessels.

Authors:  Cynthia L Eccles; Regina V Tse; Maria A Hawkins; Mark T Lee; Douglas J Moseley; Laura A Dawson
Journal:  Adv Radiat Oncol       Date:  2016-01-26

8.  Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study.

Authors:  Eva Versteijne; Oliver J Gurney-Champion; Astrid van der Horst; Eelco Lens; M Willemijn Kolff; Jeroen Buijsen; Gati Ebrahimi; Karen J Neelis; Coen R N Rasch; Jaap Stoker; Marcel van Herk; Arjan Bel; Geertjan van Tienhoven
Journal:  Radiat Oncol       Date:  2017-03-23       Impact factor: 3.481

9.  4D-PET data sorting into different number of phases: a NEMA IQ phantom study.

Authors:  Pietro Mancosu; Roberto Sghedoni; Valentino Bettinardi; Federica Fioroni; Mark Anthony Aquilina; Elisa Grassi; Ferruccio Fazio; Giovanni Borasi; Maria Carla Gilardi
Journal:  J Appl Clin Med Phys       Date:  2009-10-28       Impact factor: 2.102

10.  Pancreatic Cancer detection via Galectin-1-targeted Thermoacoustic Imaging: validation in an in vivo heterozygosity model.

Authors:  Huan Qin; Baohua Qin; Chang Yuan; Qun Chen; Da Xing
Journal:  Theranostics       Date:  2020-07-14       Impact factor: 11.556
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.